Tue, Mar 3, 2015, 10:09 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Skullcandy, Inc. (SKUL) Message Board

cash2go 100 posts  |  Last Activity: Mar 2, 2015 2:31 PM Member since: Feb 8, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    U.S. Strategic National Stockpile for Smallpox

    by cash2go Feb 26, 2015 5:20 PM
    cash2go cash2go Mar 2, 2015 2:31 PM Flag

    Seeing Siga's price action recently maybe they are about to ink another sizable deal. Ebola and Measles stories help American public appreciate value of these programs. NIH says one case of smallpox found in the world would be considered catastrophic.

    Maybe boys getting into Siga know something? That is how Wall Street works. PIP to be gobbled up soon?

  • Reply to

    Teebrane do you use the ignore feature?

    by cash2go Mar 2, 2015 1:36 PM
    cash2go cash2go Mar 2, 2015 2:14 PM Flag

    Have you seen video of opening argument by Siga to Delaware Supreme Court? Ran across actual video with audio of Siga's opening presentation. Google under cvn video and you will find it. At about 2 minutes 30 seconds the attorney states that it is "fact" that Siga and Pharmathene both think the value of -246 has tripled by November 2006.
    (Siga attorney uses the tripling of value as reason that LATS terms should no longer apply)

    I'd be interested in you listening to it and give me your opinion. Another appeal at this point sounds absurd from Siga's viewpoint. I'm fine if you point out negatives in your argument. I don't love or hate a stock, I do enjoy a sensible conservation.

  • The shorts are so focused on discrediting Teebrane, it's replaced the wild speculation articles. I've seen little valuable input from the negative posters on this board.

    The original "non binding" negative posters are the real gut busters.

    Hang in there and know that your posting some very valuable insights that are read by many that are here for the long run.

  • Reply to

    Trouble in Pipville

    by sellhighdrinklow Mar 2, 2015 12:35 PM
    cash2go cash2go Mar 2, 2015 1:21 PM Flag

    I'm in no rush and have cleared cash to collect on price panics from here. This bottoming out and creep up has my trigger finger itching, especially with the Siga boyz getting some strong action.

    Pharmathene is up another $34 grand today.

  • Being short Portola.

  • No Needle. Gonna be a huge hit.

    Short term Big Pharma will battle Afreeza with everything the got. Buy the dips and hang on for a few years.

  • Reply to

    Sanofi rep in my office today.

    by doctor.stockpicker Feb 26, 2015 6:10 PM
    cash2go cash2go Mar 2, 2015 2:06 AM Flag

    Interesting observation on less basal needed.
    A1C's are going to improve with compliance and fewer post prandial spikes not occurring means less basal insulin needed to maintain targeted A1C.
    I'm guessing the compliance issue with mealtime injections is much larger than calculated. Affrezza gonna be so much simpler and why would anyone skip it because you don't have the annoying needle #$%$...

  • Reply to

    American Bar Association

    by cash2go Feb 27, 2015 12:13 AM
    cash2go cash2go Mar 1, 2015 2:55 AM Flag

    (Siga not required to pay expert witness that was not helpful)
    * Siga will be required to help pay for witness testimony that was considered helpful in determining reasonable expectations.

    Some (((speculation))) has to be used to determine reasonable expectations. Are we still beating that dead horse?

  • Reply to

    American Bar Association

    by cash2go Feb 27, 2015 12:13 AM
    cash2go cash2go Feb 27, 2015 3:04 PM Flag

    Proper Remedy
    SUPREME COURT
    Decided: May 24, 2013
    (Siga not required to pay expert witness unhelpful)
    On remand, the Vice Chancellor shall redetermine his damage award in light of this opinion and is free to reevaluate the helpfulness of expert testimony.

  • Reply to

    American Bar Association

    by cash2go Feb 27, 2015 12:13 AM
    cash2go cash2go Feb 27, 2015 2:31 PM Flag

    Note the Delaware Supreme Court says NOT TOO SPECULATIVE.
    Based on ordering for National Stockpile
    Not based on passing a phase III trial for FDA approval.
    *** A Huge difference

  • Reply to

    American Bar Association

    by cash2go Feb 27, 2015 12:13 AM
    cash2go cash2go Feb 27, 2015 2:26 PM Flag

    I think you mean too speculative. Speculative is a very broad concept.

    PharmAthene also contends that the Vice Chancellor erroneously failed to award PharmAthene its lump-sum expectation damages on the basis that they would be too speculative. We (Delaware Supreme Court) do not reach this claim either, because we reverse the Vice Chancellor’s damages award and remand for him to reconsider it in light of this opinion.

    IN THE SUPREME COURT OF THE STATE OF DELAWARE
    Decided: May 24, 2013
    page 42

  • Reply to

    Betrixaban Successfully Passes Futility Analysis

    by cash2go Feb 6, 2015 1:14 AM
    cash2go cash2go Feb 27, 2015 12:16 AM Flag

    Milestone payments of more than $500M

  • Business Law Today
    C. Stephen Bigler, Jennifer Veet Barrett said/predicted:

    ...Although the Court of Chancery has yet to determine on remand in SIGA whether there is sufficient evidence to support an award of expectation damages to remedy SIGA’s breach of an agreement to negotiate in good faith, previous decisions of the Delaware courts where expectation damages have been awarded to remedy a breach of contract provide some guidance as to what type of evidence is sufficient to prove expectation damages with reasonable certainty. In that regard, Delaware courts have found that evidence of the expectations of the non-breaching party as to value of the business transaction, such as projections, prepared at the time the transaction was being negotiated and provided to a third party is a fair representation of the expectations of the non-breaching party sufficient to support an award of expectation damages.

    For example, in WaveDivision Holdings, LLC v. Millennium Digital Media Systems, L.L.C., 2010 WL 3706624 (Del. Ch. Sept. 17, 2010), after finding that Millennium breached its contractual obligations to WaveDivision, the Court of Chancery determined that expectation damages could be calculated with reasonable certainty. The court calculated the damage award based on the profits that WaveDivision expected to generate from the transaction as set forth in projections that were prepared by WaveDivision and that were prov
    ided to its lenders in connection with its attempt to obtaining financing for the transaction. The court determined that the projections provided to the lenders were a “sound, conservative estimate as to Wave’s expectations at the time.”

  • Reply to

    U.S. Strategic National Stockpile for Smallpox

    by cash2go Feb 26, 2015 5:20 PM
    cash2go cash2go Feb 26, 2015 5:25 PM Flag

    Siga is not going to let Pharmathene get -246 rights, period. Plenty of cash going to smallpox firms in the future.

  • Sept. 4, 2014 (GLOBE NEWSWIRE
    This is the second option exercised to purchase additional doses of IMVAMUNE to maintain the stockpile in case of a public health emergency. The two replenishment options are valued at USD 228 million

    April 24, 2008 3:00 am
    Acambis wins US smallpox vaccine contract

    Acambis, the vaccine maker, has won a $425m (£215m) contract to supply the US government with a smallpox vaccine for 10 years.
    ...Acambis has already supplied the US government with more than $500m of standard smallpox vaccines as the country stockpiled amid fears of "bioterrorism".

  • Reply to

    Appeal due march 2nd

    by beepoe111 Feb 24, 2015 6:04 PM
    cash2go cash2go Feb 26, 2015 1:08 PM Flag

    William J. Haynes II, SIGA's General Counsel, commented, "We believe the decision to award expectation damages is not supported by law with the amount of the award being completely speculative, conjectural and arbitrary.

    Delaware Supreme Courts Words:

    PharmAthene also contends that the Vice Chancellor erroneously failed to award PharmAthene its lump­sum expectation damages on the basis that they would be too speculative.114 We do not reach this claim either

    IN THE SUPREME COURT OF THE STATE OF DELAWARE
    Decided: May 24, 2013

    page 42 Less

    If Perelman plays nice Siga Shareholders and Pharmatene shareholders coiuld be very happy

  • Reply to

    Too Speculative?

    by cash2go Feb 26, 2015 2:03 AM
    cash2go cash2go Feb 26, 2015 12:33 PM Flag

    Tee,
    "The significance is in who brings it up (The Delaware Supreme Court in May 2013)."

    again on page 29

    70 Id. at *24; see id. at *8 (citation omitted) (during merger negotiations and after receiving a significant grant, “Konatich wrote to [Hruby] that ‘it is a damn shame we had to merge,’ [and] Hruby responded, ‘You got that right. . . . Had [the former CEO of SIGA] not gotten us behind the curve through ineptitude, we would still be an independent company and standing to make some real dough . . . we could have gone all the way ourselves’” (omissions in original)); id. at *9 (citation omitted) (before terminating the merger, an in­house MAF lawyer asked in an email, “should SIGA continue with its merger plans or should it try to go it alone?” (internal quotation marks omitted)).

  • Reply to

    Too Speculative?

    by cash2go Feb 26, 2015 2:03 AM
    cash2go cash2go Feb 26, 2015 2:47 AM Flag

    Delaware Supreme Court :

    On remand, the Vice Chancellor shall redetermine his damage award in light of this opinion and is free to reevaluate the helpfulness of expert testimony.

    Decided: May 24, 2013
    page 41

  • Reply to

    Too Speculative?

    by cash2go Feb 26, 2015 2:03 AM
    cash2go cash2go Feb 26, 2015 2:27 AM Flag

    PharmAthene also contends that the Vice Chancellor erroneously failed to award PharmAthene its lump­sum expectation damages on the basis that they would be too speculative.114 We do not reach this claim either

    IN THE SUPREME COURT OF THE STATE OF DELAWARE
    Decided: May 24, 2013

    page 42

  • Reply to

    Too Speculative?

    by cash2go Feb 26, 2015 2:03 AM
    cash2go cash2go Feb 26, 2015 2:08 AM Flag

    After primate results NIH was very interested in -246

    In September 2006, the National Institutes of Health awarded SIGA $16.5 million to develop the drug. After receiving this grant, SIGA representatives expressed remorse over having agreed to the merger.18

SKUL
10.35-0.310(-2.91%)Mar 3 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.